Day: May 16, 2024

Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May 16, at 8:30 AM ET OCALA, Fla., May 16, 2024 (GLOBE NEWSWIRE) — AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today reported its financial results for the first quarter 2024. As previously announced, the Company will host a conference call and webcast today, Thursday, May 16, 2024, at 8:30 AM ET (details below). “AIM is making fundamental progress across our clinical development programs and continues to be encouraged by Ampligen’s potential. We recently reported encouraging top-line data across our pipeline. We also recently completed cGMP manufacturing of 9,000 vials of Ampligen. Both of these successes are extremely important...

Announcement no. 9-2024 16 May 2024 North Media CEO Lasse Ingemann Brodt commented on the results for Q1 2024:“In the first quarter of 2024, with performance in line with expectations, we focused on integrating SDR Svensk Direktreklam in the North Media Group. We have taken the first steps to exploit the potential for mutual development with FK distribution, including the transition to shared use of the Danish production systems and planned testing of automated packaging of printed matter for the Swedish market in Q2 2024. In Digital Services, the results were impacted by increased costs for strategic development of the businesses, which was expected. Based on greater insight into SDR’s business, we are narrowing our full-year guidance.” Guidance for 2024 The Group narrows its revenue and EBITDA guidance. Revenue is now expected to be...

Sales through new online portal increase 31% over the same period last year Gross margin for the first quarter of 2024 increases to 74.5% from 72.7% for the same period last year Reports steady progress on reimbursement strategy for the CompuFlo® Epidural System ROSELAND, N.J., May 16, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and announces financial results for the first quarter ended March 31, 2024. Arjan Haverhals, CEO and President of Milestone Scientific, stated, “I am pleased to report our domestic, direct sales strategy within our dental segment has proven effective, as a result of our new online sales portal, which recorded growth of 31% over the same period...

Tel Aviv, Israel, May 16, 2024 (GLOBE NEWSWIRE) — Jeffs’ Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced preliminary unaudited financial results for Fort Products Ltd. (“Fort”), its wholly owned subsidiary, on its revenue for sales on Amazon Marketplace, according to the data received from the Amazon seller central. The following results are for the first quarter of 2024, starting on January 1, 2024, and ending on March 31, 2024 (the “Period”). Fort’s Amazon generated revenues for the Period, amounted to approximately $2.125 million (£1.7 million), representing an increase of 55% compared $1.375 million (£1.1 million) at the same period of 2023. Profit for the Period, attributed directly to Fort’s Amazon sales,...

Transformational year thanks to successful organic growth and the benefit of acquisitions First quarter profit at the top end of range for preliminary results shows continued strong performance Positive momentum continued into the second quarter with good performance in AprilNEW YORK, May 16, 2024 (GLOBE NEWSWIRE) — Marex Group plc (‘Marex’ or the ‘Group’), a diversified global financial services platform, announces strong results for the twelve months ended December 31, 2023, and a positive update for the first three months ended March 31, 2024. Ian Lowitt, Group Chief Executive Officer, commented: “2023 was another exceptional year where we transformed the scale and scope of the firm and maintained our record of delivering sequential growth over each of the last nine years, with an Adjusted Operating Profit compound...